Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting

M Charabati, MA Wheeler, HL Weiner, FJ Quintana - Cell, 2023 - cell.com
Multiple sclerosis (MS) is a chronic inflammatory and degenerative disease of the central
nervous system afflicting nearly three million individuals worldwide. Neuroimmune …

[HTML][HTML] Multiple sclerosis: mechanisms and immunotherapy

C Baecher-Allan, BJ Kaskow, HL Weiner - Neuron, 2018 - cell.com
Multiple sclerosis (MS) is an autoimmune disease triggered by environmental factors that act
on a genetically susceptible host. It features three clinical stages: a pre-clinical stage …

B cells in autoimmune and neurodegenerative central nervous system diseases

JJ Sabatino Jr, AK Pröbstel, SS Zamvil - Nature Reviews Neuroscience, 2019 - nature.com
B cells are essential components of the adaptive immune system and have important roles
in the pathogenesis of several central nervous system (CNS) diseases. Besides producing …

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

CH Polman, SC Reingold, B Banwell… - Annals of …, 2011 - Wiley Online Library
New evidence and consensus has led to further revision of the McDonald Criteria for
diagnosis of multiple sclerosis. The use of imaging for demonstration of dissemination of …

Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation

L Mayo, SA Trauger, M Blain, M Nadeau, B Patel… - Nature medicine, 2014 - nature.com
Astrocytes have complex roles in health and disease, thus it is important to study the
pathways that regulate their function. Here we report that lactosylceramide (LacCer) …

IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39

ID Mascanfroni, A Yeste, SM Vieira, EJ Burns… - Nature …, 2013 - nature.com
Dendritic cells (DCs) control the balance between effector T cells and regulatory T cells in
vivo. Hence, the study of DCs might identify mechanisms of disease pathogenesis and guide …

Potassium channel KIR4. 1 as an immune target in multiple sclerosis

R Srivastava, M Aslam, SR Kalluri… - … England Journal of …, 2012 - Mass Medical Soc
Background Multiple sclerosis is a chronic inflammatory demyelinating disease of the central
nervous system. Many findings suggest that the disease has an autoimmune pathogenesis; …

Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis

A Yeste, M Nadeau, EJ Burns… - Proceedings of the …, 2012 - National Acad Sciences
The immune response is normally controlled by regulatory T cells (Tregs). However, Treg
deficits are found in autoimmune diseases, and therefore the induction of functional Tregs is …

Tolerogenic nanoparticles suppress central nervous system inflammation

JE Kenison, A Jhaveri, Z Li, N Khadse… - Proceedings of the …, 2020 - National Acad Sciences
Therapeutic approaches for the induction of immune tolerance remain an unmet clinical
need for the treatment of autoimmune diseases, including multiple sclerosis (MS). Based on …

[HTML][HTML] Inflammation, demyelination, and degeneration—recent insights from MS pathology

C Stadelmann, C Wegner, W Brück - Biochimica et Biophysica Acta (BBA) …, 2011 - Elsevier
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system
which responds to anti-inflammatory treatments in the early disease phase. However, the …